The company’s proprietary Nanoaqualip™ drug delivery technology and new molecule drugs generate more commercial opportunities than we can pursue independently. Strategic partnering is therefore a critical component of our ability to advance company’s therapeutic products into clinical development leading to successful launch in the market. Our objective is to selectively partner at strategic stages of the development process while retaining selected therapeutic programs to develop independently. We want to integrate our proprietary technology platform into the best fit companies to achieve rapid development of drugs for the benefit of patient population.
Partners may choose licensing or co-development arrangements for our pre-clinical and clinical stage drugs under development. The company brings a full range of capabilities to support drug delivery, development and manufacturing. This commitment of support makes Jina Pharmaceuticals an ideal partner for the industry leading pharmaceutical and biotechnology companies.
Partners may also work with the company to advance their own proprietary compounds/drugs by utilizing our Nanoaqualip™ technology for the treatment of cancer, infectious diseases, and dermatological products, as well as veterinary drugs.
Please feel free to contact us if you would be interested to discuss partnering opportunities with Jina Pharmaceuticals.
Saif Sheikh, Ph.D. MBA
Vice President, Business Development
Jina Pharmaceuticals Inc.
28100 North Ashley Circle, Suite 103
Libertyville, IL 60048, USA